RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Wave Life Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-15 5:04 pm Unchanged | 2025-12-11 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT L.P. | 25,453,010 13.400% | 0 (Unchanged) | Filing |
| 2025-11-13 8:47 pm Purchase | 2025-11-11 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT L.P. | 25,453,010 14.600% | 38,845 (+0.15%) | Filing |
| 2024-10-01 5:47 pm Purchase | 2024-09-27 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT L.P. | 25,414,165 16.000% | 8,144,354 (+47.16%) | Filing |
| 2022-06-21 4:35 pm Purchase | 2009-02-28 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT L.P. | 17,269,811 19.990% | 9,441,354 (+120.60%) | Filing |
| 2021-11-12 4:30 pm Purchase | 2009-02-28 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT L.P. | 7,828,457 13.300% | 5,250 (+0.07%) | Filing |
| 2021-08-18 5:30 pm Purchase | 2009-02-28 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT L.P. | 7,823,207 15.390% | 48,000 (+0.62%) | Filing |